FUROSEMIDE | A216629 | GRAVITI PHARMACEUTICALS PRIVATE LTD
Highest NADAC/Unit
$0.0521
per ea
Lowest NADAC/Unit
$0.0272
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 64980056401FUROSEMIDE 80 MG TABLET | $0.0521 | EA | Generic | — | 2026-06-17 |
| 64980056450FUROSEMIDE 80 MG TABLET | $0.0521 | EA | Generic | — | 2026-06-17 |
| 64980056301FUROSEMIDE 40 MG TABLET | $0.0307 | EA | Generic | — | 2026-06-17 |
| 64980056310FUROSEMIDE 40 MG TABLET | $0.0307 | EA | Generic | — | 2026-06-17 |
| 64980056201FUROSEMIDE 20 MG TABLET | $0.0272 | EA | Generic | — | 2026-06-17 |
| 64980056210FUROSEMIDE 20 MG TABLET | $0.0272 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.